Showing posts with label Microfluidics Market trends. Show all posts
Showing posts with label Microfluidics Market trends. Show all posts

Monday, 27 December 2021

Microfluidics Market Analysis Global Size, Share, Growth, Industry Demand And Forecast To 2028

 Microfluidics Market Size & Share | Global Industry Forecast Report, 2028


The global microfluidics market size is expected to reach USD 55.18 billion by 2028 according to a new study by Polaris Market Research. The report “Microfluidics Market Share, Size, Trends, Industry Analysis Report, By Material (Silicon, Glass, Polymer, PDMS); Technology (Medical, Non-medical); By Application; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The major factors driving the growth of the market are the need for miniaturization of PoC devices and the need to develop new 3D culture models that can mimic the pathophysiology of human organs for disease models and drug screening.

 

The use of the product will greatly enhance PoC devices in speed and accuracy. The increased incidences of chronic diseases such as diabetes led to the increased use of PoC devices as these devices can help monitor the disease in a home setup.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-sample

 

New culture models such as Organ-on-a-chip model systems are developed using microfluidic technology. These systems can mimic the physiology of organs such as lungs, kidneys, and others. They have applications in disease modeling to understand the pathophysiology of the disease and in drug screening as currently available in vitro platforms for drug screening have limitations.

 

In 2021, LumiraDx received approval for a microfluidic immunofluorescence assay to detect SARS-CoV-2 antigen in Japan and Brazil. In January 2021, LexaGene announced the launch of the MiQLab system from research-only use to POC use to detect the SARS-CoV-2 virus after receiving emergency use authorization (EUA) in the U.S.

 

COVID-19 pandemic is expected to further fuel the growth of the global industry. There is a time-bound urgency to develop rapid diagnostic tests and screen and develop drugs in pandemic times to bring down the pandemic under control. The product-based PCR will help significantly in the diagnosis of disease.

 

Get Discount Offer : https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-discount-pricing

 

 

Market Participants such as Roche Ltd, PerkinElmer, Agilent Technologies, Inc., Danaher Corporation, Abbott Laboratories, Life Technologies Corporation, Thermo Fisher Scientific, Biomerieu, Illumina, Inc., Qiagen, Bio-Rad Laboratories, Elveflow, Micronit Micro Technologies B.V., Cellix Ltd., and Fluidigm Corporation are few key players operating in the global industry.

 

Polaris Market Research has segmented the microfluidics market report on the basis of technology, material, application, and region:

 

Microfluidics, Technology Outlook (Revenue – USD Million, 2016 – 2028)

  • Medical
  • PCR & RT-PCR
  • Gel Electrophoresis
  • Microarrays
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Others
  • Non-medical

Microfluidics, Material Outlook (Revenue – USD Million, 2016 – 2028)

  • Silicon
  • Glass
  • Polymer
  • Polydimethylsiloxane (PDMS)
  • Others

Microfluidics, Application Outlook (Revenue – USD Million, 2016 – 2028)

  • Lab-On-A-Chip
  • Organs-On-Chips
  • Continuous Flow Microfluidic
  • Optofluidics and Microfluidic
  • Acoustofluidics and Microfluidics
  • Electrophoresis and Microfluidics

 

Friday, 10 December 2021

Microfluidics Market Detailed Analytical Overview By 2028

 The report “Global Microfluidics Market  2028” from PMR Market Research includes data and information about market structure and size. The purpose of this research is to give market knowledge and strategic insights to assist in decision making, making informed investment decisions, and identifying potential growth opportunities.


The global microfluidics market size is expected to reach USD 55.18 billion by 2028 according to a new study by Polaris Market Research.


The research report adopts primary and secondary research approaches, resulting in a precise and accurate insight into the Microfluidics industry. To examine the segments and provide a fair assessment of their influence on the worldwide market, analysts utilized a top-down and bottom-up strategy. The study begins with a market overview, which includes a brief description of the industry's current state as well as the major segments. It also lists the leading players in the global market.

Microfluidics Market Forecast till 2028


Download Sample Copy :  https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-sample


A Porter's five forces analysis and SWOT analysis are included in the research study on the global Microfluidics market, which empower to determine the market's accurate trajectory. Such effective market analysis tools helps to identify market’s major drivers, restraints, risks, and market opportunities. In addition to this, the research report also features statistics for global market as well as different regional markets.


Market Segmentation

The report features in-depth segmentation and sub-segmentation of the target market. The executive summary of the Microfluidics market research provides a quick overview of the market. It discusses the key sectors and companies projected to shape the market in the coming years. The executive summary provides a non-biased view of the market. It describes how the market's demand and supply will be affected by shifting demographics. It goes over the regulatory adjustments that are expected to change people's buying behavior.


Exclusive Discount Offer on this Research Report : https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-discount-pricing


COVID-19 Pandemic Impact Analysis

This Microfluidics market study discusses the impact of the COVID-19 pandemic on macro and micro aspects of business, hurdles encountered by each sector, and continuous efforts to turn this crisis into an opportunity. The research report also discusses government policies for recovering the economy in detail, in order to assist businesses in expanding or entering new markets, as well as introducing new products and services.


Competitive Analysis

This section of the research study focuses on the market's leading players and competitive landscape. The Microfluidics market study provides a list of strategic efforts undertaken by companies in recent years, as well as those anticipated in the near future. The financial prospects of these companies, their research and development activities, and their expansion plans for the near future have all been noted by researchers. The global market research report is a serious endeavor to provide interested readers with a thorough view of the market.


Market participants such as : Roche Ltd, PerkinElmer, Agilent Technologies, Inc., Danaher Corporation, Abbott Laboratories, Life Technologies Corporation, Thermo Fisher Scientific, Biomerieu, Illumina, Inc., Qiagen, Bio-Rad Laboratories, Elveflow, Micronit Micro Technologies B.V., Cellix Ltd., and Fluidigm Corporation


Key Reason to buy this Microfluidics Market Research Report

  • It provides analytical data along with strategic planning approaches to help businesses make informed decisions.


  • The market's dynamics, such as drivers, restraints, trends, and opportunities, are examined by researchers.

 

  • It provides a wealth of information on current events that will have an impact on the market's overall performance.

 

  • It includes regional analysis of the global market as well as corporate profiles of various stakeholders.

 

Read  More :

https://www.prnewswire.com/news-releases/sucrose-esters-market-size-worth-126-8-million-by-2028--cagr-5-8-polaris-market-research-301313642.html?tc=eml_cleartime

https://www.prnewswire.com/news-releases/true-wireless-earbuds-market-size-worth-14-51-billion-by-2028--cagr-14-4-polaris-market-research-301317177.html

https://www.prnewswire.com/news-releases/transplantation-market-size-worth-19-52-billion-by-2028--cagr-11-5-polaris-market-research-301325522.html

Thursday, 21 October 2021

Microfluidics Market 2021 Opportunities, Challenges, Strategies & Forecasts 2028

 The global microfluidics market size is expected to reach USD 55.18 billion by 2028 according to a new study by Polaris Market Research. The report “Microfluidics Market Share, Size, Trends, Industry Analysis Report, By Material (Silicon, Glass, Polymer, PDMS); Technology (Medical, Non-medical); By Application; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The major factors driving the growth of the market are the need for miniaturization of PoC devices and the need to develop new 3D culture models that can mimic the pathophysiology of human organs for disease models and drug screening.

 

The use of the product will greatly enhance PoC devices in speed and accuracy. The increased incidences of chronic diseases such as diabetes led to the increased use of PoC devices as these devices can help monitor the disease in a home setup.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-sample

 

New culture models such as Organ-on-a-chip model systems are developed using microfluidic technology. These systems can mimic the physiology of organs such as lungs, kidneys, and others. They have applications in disease modeling to understand the pathophysiology of the disease and in drug screening as currently available in vitro platforms for drug screening have limitations.

 

In 2021, LumiraDx received approval for a microfluidic immunofluorescence assay to detect SARS-CoV-2 antigen in Japan and Brazil. In January 2021, LexaGene announced the launch of the MiQLab system from research-only use to POC use to detect the SARS-CoV-2 virus after receiving emergency use authorization (EUA) in the U.S.

 

COVID-19 pandemic is expected to further fuel the growth of the global industry. There is a time-bound urgency to develop rapid diagnostic tests and screen and develop drugs in pandemic times to bring down the pandemic under control. The product-based PCR will help significantly in the diagnosis of disease.

 

Get Discount Offer : https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-discount-pricing

 

 

Market Participants such as Roche Ltd, PerkinElmer, Agilent Technologies, Inc., Danaher Corporation, Abbott Laboratories, Life Technologies Corporation, Thermo Fisher Scientific, Biomerieu, Illumina, Inc., Qiagen, Bio-Rad Laboratories, Elveflow, Micronit Micro Technologies B.V., Cellix Ltd., and Fluidigm Corporation are few key players operating in the global industry.

 

Polaris Market Research has segmented the microfluidics market report on the basis of technology, material, application, and region:

 

Microfluidics, Technology Outlook (Revenue – USD Million, 2016 – 2028)

  • Medical
  • PCR & RT-PCR
  • Gel Electrophoresis
  • Microarrays
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Others
  • Non-medical

Microfluidics, Material Outlook (Revenue – USD Million, 2016 – 2028)

  • Silicon
  • Glass
  • Polymer
  • Polydimethylsiloxane (PDMS)
  • Others

Microfluidics, Application Outlook (Revenue – USD Million, 2016 – 2028)

  • Lab-On-A-Chip
  • Organs-On-Chips
  • Continuous Flow Microfluidic
  • Optofluidics and Microfluidic
  • Acoustofluidics and Microfluidics
  • Electrophoresis and Microfluidics